“▶ YEOTOP4.COM ◀ 여탑수색동오피ば수색동안마ひ수색동립카페☩수색동출장←수색동오피◀수색동키스방ⅱ수색동건마”的搜索结果，显示 161-170 项，共有 9808 项

1. 神经科- 临床试验- 妙佑医疗国际

   This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...

3. 过敏科 - 医生 - 妙佑医疗国际

   Find a doctor in the Mayo Clinic Division of Allergic Diseases.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Frailty is thought to be mediated by senescent cells and their dynamic secretome, referred to as the senescence-associated secretory phenotype (SASP). Senescent ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... 2 or 3 meningioma as measured by 6-month PFS rate.

8. 神经科- 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also, to improve disease control by decreasing the number of spinal relapses for ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 (HER2). HER2 is found on some cancer cells. When pertuzumab or trastuzumab attach to HER2, the signals that tell the cells to grow are blocked and the ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... 2 or 3 meningioma as measured by 6-month PFS rate.